Health Care professionals

For health care professionals

Seattle Cancer Care Alliance (SCCA) is a nationally recognized treatment center that provides advanced therapies and clinical trials for cancers and other blood disorders. SCCA unites the doctors and technology from Fred Hutchinson Cancer Research Center, UW Medicine and Seattle Children's and provides a variety of resources for community doctors and other healthcare professionals.

Refer a Patient

News from our blog

Kidney cancer: Multidisciplinary clinic helps navigate changing treatment landscape

Treatment for metastatic kidney cancer is evolving rapidly, as providers move away from performing upfront cytoreductive surgery and navigate a growing number of new therapies and combined drug regimens. SCCA’s Kidney Cancer Multispecialty Clinic (KCMC) offers multidisciplinary consultations and care to help community oncologists and their patients understand and access the latest treatment options.

View Story

12th Annual Virtual Comprehensive Hematology and Oncology Review Course

Join our renowned experts from Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center and the University of Washington for the 12th Annual Comprehensive Hematology and Oncology Review Course.

View Story

Sarcoma: Targeted agents and multi-modal approaches are improving outcomes and transforming care

Sarcoma: Innovative approaches are transforming care.

The sarcoma treatment landscape is changing dramatically, with a growing number of FDA-approved drugs and clinical trials offering new hope and improving outcomes for patients whose treatment options were very limited just a few years ago.

View Story

When to refer leukemia and lymphoma patients for CAR T-cell therapy

CAR T-cell therapy for leukemia and lymphoma patients can be an incredibly effective treatment. That means understanding when to refer a patient for treatment is critical.

View Story

Visit Oncology Insights Blog

Podcasts

Recent podcasts

Kidney Cancer Multispecialty Clinic

Transplant in Older Patients

All Podcasts

Publications

Recent publications

FDA grants accelerated approval to sacituzumab govitecan for advanced urothelial cancer

Journal of Clinical Investigation: Dr. Stanley Riddell, professor (Medical Oncology) is senior author of “A therapeutic cancer vaccine delivers antigens and adjuvants to lymphoid tissues using genetically modified T cells”

Nature Medicine: Dr. Stanley Riddell, professor (Medical Oncology) is senior author of “Tumor-infiltrating lymphocytes make inroads in non-small-cell lung cancer”

Science: Dr. Stanley Riddell is an author of “Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo function”

New services

Bladder Cancer: Blue Light Cystopscopy

Brain and Spine Metastases Clinic

Clinical trials

Highlighted clinical trials

A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
Investigator: Sylvia M. Lee, MD

A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL) (TRANSCEND FL)
Investigator: David G. Maloney, MD, PhD

A Study of CART-PSMA-TGFßRDN in Patients With Metastatic Castration Resistant Prostate Cancer
Investigator: Dr. Michael Schweizer

View All Clinical Trials

Subscribe to our SCCA/UWMC clinical trial portfolios

Skin oncology research portfolio: Contact SLMskin@seattlecca.org
- Monthly email communication includes PDF file of available clinical trials organized by disease setting for melanoma and Merkel cell carcinoma
GU oncology research portfolio: Contact SLMgu@seattlecca.org
- Monthly email communication includes PDF files of available clinical trials organized by disease setting for prostate, bladder and kidney cancer
Heme and heme malignancies: Subscribe by signing up for Oncology Insights
Breast, Heme and heme malignancies: Subscribe by signing up for Oncology Insights